Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing
Go back to Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing| Medtronic Inc. (NYSE: MDT) | Delayed: 79.34 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.34 | 52 Week High | $89.27 | |||
| Open | $79.34 | 52 Week Low | $71.03 | |||
| Day High | $79.34 | P/E | 22.54 | |||
| Day Low | $79.34 | EPS | $3.52 | |||
| Volume | 4,155 | |||||
